filmov
tv
Salvage Radiation, Lutetium-177, 3+4=7, & What is Cribriform? | Mark Scholz, MD | PCRI
Показать описание
Medical Oncologist, Mark Scholz MD, fields questions from our YouTube comments section. In this episode, PCRI's viewers asked, "Can SpaceOAR be utilized after radical prostatectomy (prostate surgery) for salvage radiation treatment?" "Is lutetium-177 an option for someone who has already had spot radiation treatment to a small number of metastatic lesions," and, "What are the implications of "cribriform" when it is listed as present on the pathology report of a man who has mostly Gleason 3+3=6 and a small amount of Gleason 3+4=7?"
0:13 Can a post-radical prostatectomy patient utilize SpaceOAR if they are being treated with salvage radiation? (SpaceOAR is a gel that is used to separate the prostate and the rectum to reduce the dose of radiation delivered to the rectum.)
2:05 Can a man have lutetium-177 if they have already received spot radiation to oligometastatic lesions?
3:45 "My pathology report had a lot of 3+3=6 and a small amount of 3+4=7 which I thought would make me favorable intermediate-risk; however, the report also says that it is "cribriform." Can you explain what that means and its implications?"
Who we are:
The information on the Prostate Cancer Research Institute's YouTube channel is provided with the understanding that the Institute is not engaged in rendering medical advice or recommendation. The information provided in these videos should not replace consultations with qualified health care professionals to meet your individual medical needs.
#ProstateCancer #MarkScholzMD #PCRI
0:13 Can a post-radical prostatectomy patient utilize SpaceOAR if they are being treated with salvage radiation? (SpaceOAR is a gel that is used to separate the prostate and the rectum to reduce the dose of radiation delivered to the rectum.)
2:05 Can a man have lutetium-177 if they have already received spot radiation to oligometastatic lesions?
3:45 "My pathology report had a lot of 3+3=6 and a small amount of 3+4=7 which I thought would make me favorable intermediate-risk; however, the report also says that it is "cribriform." Can you explain what that means and its implications?"
Who we are:
The information on the Prostate Cancer Research Institute's YouTube channel is provided with the understanding that the Institute is not engaged in rendering medical advice or recommendation. The information provided in these videos should not replace consultations with qualified health care professionals to meet your individual medical needs.
#ProstateCancer #MarkScholzMD #PCRI
Комментарии